Calculus is delighted to announce the appointments of Matthew Moynes and Frank Spurway as Investor Relations Assistant Director and Analyst respectively. Matthew joins Calculus from Barclays Wealth where he was the Head of Venture Capital Products responsible for managing the … Continued
Calculus EIS Fund was the first approved EIS Fund on the market 22nd iteration of the Fund launched this week The last 18 months have seen 10 exits across the EIS Funds including 6x return for ActiveOps Calculus Capital are … Continued
Hardman & Co’s latest EIS Navigator Podcast Episode, hosted by Dr Brian Moretta FFA, featured Calculus Capital CEO John Glencross on the topic of “long term perspective on EIS and VCT investing”. You can listen below.
Brouhaha Entertainment was founded by experienced producers: Oscar nominated Gabrielle Tana, Independent film industry pioneer Troy Lum and producer Andrew Mason Founders have successfully produced 27 films and 9 television projects to date, featuring top talent from around the globe … Continued
Calculus successfully exit Mologic by sale to new philanthropic entity Global Access Health London 19 July 2021: Calculus Capital (“Calculus”), pioneers of the tax efficient investment industry, is pleased to announce the successful sale of Mologic Limited (“Mologic” or “the … Continued
The Annual General Meeting (AGM) of Calculus VCT plc (the “Company”) will be held at 12.30pm on 8 July 2021. The AGM is an important event in the Company’s corporate calendar, providing an opportunity for shareholders to meet the board … Continued
Calculus VCT has invested £0.5m into Spectral MD through an oversubscribed inital public offering onto AIM, on Tuesday 22 June. The Dallas-based firm, which is building notable presence in the UK as part of its product launch effort, produces predictive … Continued
– 2% off the initial fee until 29 June, apply before this date to receive the summer 2021 dividend – Target annual tax free dividend of 4.5% of NAV – Portfolio of entrepreneurial, growth orientated companies across technology, healthcare and … Continued
The University of Edinburgh spin-out is developing potentially lifesaving products that help reduce complications and high death rates amongst dialysis patients. Incoming institutional investor Calculus Capital has participated in a funding round with existing investors Downing Ventures and Mercia, alongside … Continued
Biotech sector-leaders combine tools, talent, and technologies to drive life science discovery forward Merger accompanied by £3.8million ($5.3m USD) investment across existing shareholders and new investors, which will be used to fund recruitment and growth of the business Axol Bioscience … Continued
